Analysts expect IDEAYA Biosciences, Inc. to report revenue of 19.65 M for Q4 26, against a range of 18.57 M to 20.74 M. The most recent reported quarter, Q3 26, came in at 10.24 M, a 44.9% beat against the 7.07 M consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 7.00 M | 0.00 | 0.00 | 207.83 M | 10.88 M | 6.56 M | 8.86 M | 10.24 M | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | 4.96 M | 2.43 M | 4.50 M | 6.95 M | 6.40 M | 5.33 M | 7.75 M | 7.65 M | 20.74 M | 11.32 M | 14.65 M | 44.13 M | -1.39 M | 60.97 M | 79.74 M | 109.51 M | |||||||||
| Low Estimate | 4.58 M | 2.15 M | 4.17 M | 6.43 M | 5.38 M | 4.48 M | 7.18 M | 6.48 M | 18.57 M | 10.47 M | 13.37 M | 40.68 M | -1.66 M | 53.66 M | 65.81 M | 99.61 M | |||||||||
| Consensus Estimate | 4.77 M | 2.29 M | 4.33 M | 6.69 M | 5.89 M | 4.91 M | 7.47 M | 7.07 M | 19.65 M | 10.90 M | 14.01 M | 42.41 M | -1.52 M | 57.32 M | 72.78 M | 104.56 M |
Analysts expect IDEAYA Biosciences, Inc. to report earnings per share of -1.21 for Q4 26, against a range of -1.27 to -1.15. The most recent reported quarter, Q3 26, came in at -1.22, a 7.0% miss against the -1.14 consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -1.49 | -0.82 | -0.88 | 1.47 | -0.94 | -1.11 | -1.22 | -1.22 | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | -0.55 | -0.57 | -0.74 | -0.77 | -0.96 | -0.90 | -0.98 | -1.09 | -1.15 | -1.21 | -1.21 | -1.04 | -1.28 | -0.87 | -0.75 | -0.58 | |||||||||
| Low Estimate | -0.67 | -0.69 | -0.86 | -0.83 | -1.02 | -1.02 | -1.06 | -1.19 | -1.27 | -1.31 | -1.29 | -1.18 | -1.56 | -0.95 | -0.87 | -0.62 | |||||||||
| Consensus Estimate | -0.61 | -0.63 | -0.80 | -0.80 | -0.99 | -0.96 | -1.02 | -1.14 | -1.21 | -1.26 | -1.25 | -1.11 | -1.42 | -0.91 | -0.81 | -0.60 |
Pull Wall Street consensus for IDEAYA Biosciences, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=IDYA&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "IDYA", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=IDYA&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();